Abstract:Abstract Bone defects combined with tumors, infections, or other bone diseases are challenging in clinical practice. Autologous and allogeneic grafts are two main traditional remedies, but they can cause a series of complications. To address this problem, researchers have constructed various implantable biomaterials. However, the original pathological microenvironment of bone defects, such as residual tumors, severe infection, or other bone diseases, could further affect bone regeneration. Thus, the rational design of versatile biomaterials with integrated bone therapy and regeneration functions is in great demand. Many strategies have been applied to fabricate smart stimuli-responsive materials for bone therapy and regeneration, with stimuli related to external physical triggers or endogenous disease microenvironments or involving multiple integrated strategies. Typical external physical triggers include light irradiation, electric and magnetic fields, ultrasound, and mechanical stimuli. These stimuli can transform the internal atomic packing arrangements of materials and affect cell fate, thus enhancing bone tissue therapy and regeneration. In addition to the external stimuli-responsive strategy, some specific pathological microenvironments, such as excess reactive oxygen species and mild acidity in tumors, specific pH reduction and enzymes secreted by bacteria in severe infection, and electronegative potential in bone defect sites, could be used as biochemical triggers to activate bone disease therapy and bone regeneration. Herein, we summarize and discuss the rational construction of versatile biomaterials with bone therapeutic and regenerative functions. The specific mechanisms, clinical applications, and existing limitations of the newly designed biomaterials are also clarified.

Microenvironment-responsive nanocarriers for targeted bone disease therapy

Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment

Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease

Bone targeted nano-drug and nano-delivery

Drug Delivery Based on Nanotechnology for Target Bone Disease.

Nanoparticle-Based Drug Delivery Systems for Enhancing Bone Regeneration

Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics

Smart Cargo Delivery System based on Mesoporous Nanoparticles for Bone Disease Diagnosis and Treatment

Microenvironment‐Responsive Targeted Nanomedicine for a Collaborative Integration of Tumor Theranostics and Bone Defect Repair

Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

Targeting strategies for bone diseases: signaling pathways and clinical studies

Recent advances in smart stimuli-responsive biomaterials for bone therapeutics and regeneration

Microenvironment‐Responsive Targeted Nanomedicine for a Collaborative Integration of Tumor Theranostics and Bone Defect Repair (Adv. Healthcare Mater. 27/2024)

Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.

Alendronate-functionalized hypoxia-responsive polymeric micelles for targeted therapy of bone metastatic prostate cancer

Bone-targeted biomaterials: Strategies and applications

Stimuli-Sensitive Nanotherapies for the Treatment of Osteoarthritis

Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms

Smart drug delivery systems for precise cancer therapy

Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment